Phase 4Not yet recruiting
Comparing Drospirenone and Norethindrone for Postpartum Hypertension Management in Preeclampsia
A Randomized Trial Comparing Drospirenone and Norethindrone for Postpartum Hypertension Management in Preeclampsia
- Sponsor
- Oregon Health and Science University (Academic or other)
- Enrollment
- 50 planned
- Conditions
- Hypertension; Preeclampsia
- Interventions
- Norethindrone 0.35 MG; Drospirenone
- Ages
- adults, older adults
- Registry
- NCT07293728
Full record on ClinicalTrials.gov
From the registry
This is an open-label, randomized feasibility trial in which participants admitted to Oregon Health \& Science University (OHSU) after a pregnancy complicated by preeclampsia who are considering a progestin-only pill contraception postpartum will be randomized to norethindrone or drospirenone for 6 weeks following hospital discharge.
Primary outcomes
- Blood Pressure
History
Primary completion expected
Expected to start
Last registry update
Registered